Announced Sat, 11 Jul · 17:36 IST
Sandu Pharma MD Passes Away; New CMD and Independent Director Appointed
Management Changes View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.2%1-day move
₹41.00
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-1.2+0.0-3.4-1.5—+0.0————
Up moveDown movePending
AI summary
Board noted the passing of Managing Director Umesh B. Sandu on 19 June 2026. Dr. Neeti Madan Kapre (ENT specialist) appointed as Additional Non-Executive Independent Director for 5 years from 11 July 2026. Balram Viswanathan, previously Chairman and Independent Director, redesignated as Chairman and Managing Director for 3 years. Audit, Nomination and Remuneration, and Stakeholders Relationship Committees reconstituted. Vigil Mechanism Policy updated to reflect new CMD name.
Likely market impact
Successor CMD has prior board familiarity, easing transition, but sudden loss of founding family leader may weigh on sentiment in the near term.